SK285165B6 - Tetrahydropyridoétery, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents
Tetrahydropyridoétery, farmaceutický prostriedok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK285165B6 SK285165B6 SK399-2001A SK3992001A SK285165B6 SK 285165 B6 SK285165 B6 SK 285165B6 SK 3992001 A SK3992001 A SK 3992001A SK 285165 B6 SK285165 B6 SK 285165B6
- Authority
- SK
- Slovakia
- Prior art keywords
- och
- hydroxy
- dimethyl
- phenyl
- methoxyethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843504 | 1998-09-23 | ||
| EP98117988 | 1998-09-23 | ||
| PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK3992001A3 SK3992001A3 (en) | 2001-12-03 |
| SK285165B6 true SK285165B6 (sk) | 2006-07-07 |
Family
ID=26049024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK399-2001A SK285165B6 (sk) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoétery, farmaceutický prostriedok s ich obsahom a ich použitie |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6436953B1 (enExample) |
| EP (1) | EP1115725B1 (enExample) |
| JP (1) | JP4145492B2 (enExample) |
| KR (1) | KR100668400B1 (enExample) |
| CN (2) | CN100506821C (enExample) |
| AT (1) | ATE231862T1 (enExample) |
| AU (1) | AU763463B2 (enExample) |
| BG (1) | BG65195B1 (enExample) |
| BR (1) | BR9914044A (enExample) |
| CA (1) | CA2344251A1 (enExample) |
| CZ (1) | CZ292335B6 (enExample) |
| DE (1) | DE69905178T2 (enExample) |
| DK (1) | DK1115725T3 (enExample) |
| EA (1) | EA005377B1 (enExample) |
| EE (1) | EE04677B1 (enExample) |
| ES (1) | ES2191464T3 (enExample) |
| GE (1) | GEP20032926B (enExample) |
| HK (1) | HK1038360B (enExample) |
| HR (1) | HRP20010224A2 (enExample) |
| HU (1) | HUP0102990A3 (enExample) |
| ID (1) | ID28896A (enExample) |
| IL (2) | IL142063A0 (enExample) |
| NO (1) | NO317304B1 (enExample) |
| NZ (1) | NZ510610A (enExample) |
| PL (1) | PL193616B1 (enExample) |
| PT (1) | PT1115725E (enExample) |
| RS (1) | RS50145B (enExample) |
| SI (1) | SI1115725T1 (enExample) |
| SK (1) | SK285165B6 (enExample) |
| TR (1) | TR200100805T2 (enExample) |
| WO (1) | WO2000017200A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436953B1 (en) * | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| AU3966600A (en) | 1999-04-17 | 2000-11-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Haloalkoxy imidazonaphthyridines |
| CA2285516C (en) * | 1999-05-12 | 2010-12-07 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| PL365165A1 (en) * | 2000-03-29 | 2004-12-27 | Altana Pharma Ag | Tricyclic imidazopyridines |
| CZ20023194A3 (cs) * | 2000-03-29 | 2003-01-15 | Altana Pharma Ag | Prekursory imidazopyridinových derivátů |
| AU1056302A (en) * | 2000-10-25 | 2002-05-06 | Byk Gulden Lomberg Chem Fab | Polysubstituted imidazopyridines as gastric secretion inhibitors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| US20040082605A1 (en) * | 2001-03-08 | 2004-04-29 | Arne Eek | Use |
| CA2452802A1 (en) | 2001-08-02 | 2003-02-20 | Altana Pharma Ag | Tricyclic epoxides |
| MXPA04001048A (es) * | 2001-08-03 | 2004-05-20 | Altana Pharma Ag | Imidazopiridinas sustituidas con alquilo, para el tratamiento de trastornos gastrointestinales. |
| WO2003014120A1 (en) * | 2001-08-03 | 2003-02-20 | Altana Pharma Ag | Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| JP2005519933A (ja) | 2002-02-15 | 2005-07-07 | アルタナ ファルマ アクチエンゲゼルシャフト | 三環式ｎ−アシル化合物 |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| HRP20041160A2 (en) * | 2002-05-07 | 2005-08-31 | Altana Pharma Ag | Novel combination for the treatment of airway disorders |
| EA008304B1 (ru) | 2002-11-19 | 2007-04-27 | Алтана Фарма Аг | 8-замещённые имидазопиридины |
| WO2004052374A1 (en) | 2002-12-12 | 2004-06-24 | Altana Pharma Ag | Combination medicament |
| EA010107B1 (ru) * | 2002-12-20 | 2008-06-30 | Алтана Фарма Аг | Силиловые простые эфиры |
| RS20050603A (sr) * | 2003-02-17 | 2007-09-21 | Altana Pharma Ag., | NOVE KOMBINACIJE I NOVA PRIMENA FARMACEUTSKIH AKTIVNIH JEDINjENjA |
| ES2335498T3 (es) | 2003-03-10 | 2010-03-29 | Nycomed Gmbh | Nuevo proceso para la preparacion de reflumilast. |
| TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
| SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
| MXPA05012463A (es) * | 2003-05-27 | 2006-01-30 | Altana Pharma Ag | Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal. |
| JP2007507425A (ja) * | 2003-08-29 | 2007-03-29 | ダイノゲン ファーマシューティカルズ，インコーポレイテッド | 胃腸管運動障害を処置するために有用な組成物 |
| PL1670482T5 (pl) | 2003-09-16 | 2022-10-03 | Covis Pharma Gmbh | Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego |
| CA2544325A1 (en) * | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| EP1697358A1 (en) | 2003-12-19 | 2006-09-06 | Altana Pharma AG | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| AR047605A1 (es) * | 2004-02-17 | 2006-01-25 | Altana Pharma Ag | Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos. |
| KR100958829B1 (ko) | 2004-09-03 | 2010-05-25 | 주식회사유한양행 | 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법 |
| MX2007002219A (es) | 2004-09-03 | 2007-05-04 | Yuhan Corp | Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion. |
| EP1784402B1 (en) | 2004-09-03 | 2011-08-03 | Yuhan Corporation | PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF |
| EP2258350B1 (en) * | 2005-03-16 | 2014-12-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
| EP2080513A1 (en) | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| MX2012000275A (es) | 2009-07-09 | 2012-02-08 | Raqualia Pharma Inc | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| EP2861571B1 (en) * | 2012-06-15 | 2017-05-03 | Bio-Pharm Solutions Co., Ltd. | Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same |
| WO2015052256A1 (en) | 2013-10-08 | 2015-04-16 | Katairo Gmbh | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| HU204828B (en) | 1987-07-16 | 1992-02-28 | Byk Gulden Lomberg Chem Fab | Process for producing new diazole derivatives and pharmaceutical compositions comprising such compounds |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| CA2196076A1 (en) * | 1994-07-28 | 1996-02-08 | Gerhard Grundler | Acyl imidazopyridines |
| SK283288B6 (sk) * | 1997-03-24 | 2003-05-02 | Altana Pharma Ag | Tetrahydropyridínové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie |
| WO1998042707A1 (en) * | 1997-03-24 | 1998-10-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyrido compounds |
| US6436953B1 (en) | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
-
1999
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en not_active Ceased
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
-
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK285165B6 (sk) | Tetrahydropyridoétery, farmaceutický prostriedok s ich obsahom a ich použitie | |
| US5665730A (en) | Pharmaceutically useful imidazopyridines | |
| HUP0001555A2 (hu) | Tetrahidro-imidazo-naftiridin származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| HU220066B (hu) | Imidazo[1,2-a]piridinek alkoxi-alkil-karbamátjai, alkalmazásuk, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| JP4138022B2 (ja) | テトラヒドロピリド化合物 | |
| SK197A3 (en) | Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use | |
| JP2003528877A (ja) | 胃腸疾患の処置のためのピラノ［２，３−ｃ］イミダゾ［−１，２−ａ］ピリジン誘導体 | |
| ZA200102107B (en) | Tetrahydropyridoethers. | |
| MXPA01003047A (en) | Tetrahydropyridoethers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20090917 |